DCF — MERRICK MEDICAL CENTER
Enterprise Value: $-54.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-54.8M
Enterprise Value
$-16.9M
PV of Cash Flows
$-37.9M
PV of Terminal Value
$-61.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $22.0M | $-3.6M | -17.0% | $-4.6M | $-4.2M |
| Year 2 | $22.6M | $-3.5M | -16.0% | $-4.5M | $-3.7M |
| Year 3 | $23.3M | $-3.4M | -15.0% | $-4.4M | $-3.3M |
| Year 4 | $24.0M | $-3.4M | -14.0% | $-4.4M | $-3.0M |
| Year 5 | $24.7M | $-3.4M | -14.0% | $-4.5M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-54.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$21.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1706793068717296
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5